Literature DB >> 21869560

A patient with idiopathic cholesterol crystal embolization: effectiveness of early detection and treatment.

Seiichiro Higo1, Akio Hirama, Kae Ueda, Akiko Mii, Tomohiro Kaneko, Kouichi Utsumi, Yasuhiko Iino, Yasuo Katayama.   

Abstract

A 72-year-old man was admitted to our hospital because of progressive renal dysfunction persisting for 1.5 months. Physical examination showed livedo reticularis of the toes of both feet, peripheral edema, and gait disturbance due to the toe pain. The levels of blood urea nitrogen (50.0 mg/dL) and creatinine (2.81 mg/dL) were elevated, and eosinophilia (10%, 870/µL) was noted. A biopsy of the area of livedo reticularis revealed cholesterin crystals. The patient had not undergone angiography, anticoagulation therapy, or antithrombotic treatment. Idiopathic cholesterol crystal embolization was diagnosed. Transesophageal echocardiography revealed intimal thickening of the aorta and plaque. Oral steroid therapy was started because of the progressive renal dysfunction. After steroid therapy, the symptoms improved. Early diagnosis and treatment are important. Renal dysfunction is a common symptom in elderly patients. Cholesterol crystal embolization should also be considered as a cause of unexplained renal dysfunction, especially in such patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21869560     DOI: 10.1272/jnms.78.252

Source DB:  PubMed          Journal:  J Nippon Med Sch        ISSN: 1345-4676            Impact factor:   0.920


  2 in total

1.  Ileus caused by cholesterol crystal embolization: A case report.

Authors:  Shunjiro Azuma; Maiko Ikenouchi; Takuji Akamatsu; Takeshi Seta; Shunji Urai; Yoshito Uenoyama; Yukitaka Yamashita
Journal:  World J Gastroenterol       Date:  2016-03-28       Impact factor: 5.742

2.  Idiopathic cholesterol crystal embolism with atheroembolic renal disease and blue toes syndrome: A case report.

Authors:  De-Jin Cheng; Lin Li; Xiang-Yue Zheng; Shui-Fu Tang
Journal:  World J Clin Cases       Date:  2022-09-06       Impact factor: 1.534

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.